Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD
Under the new FDA peptide regulations 2026, BPC-157's move to Category 2 means that compounding pharmacies will face significant restrictions in producing it
Both medications work on the GLP-1 receptor, and combining them significantly increases the risk of severe side effects like extreme nausea, dehydration, and pancreatitis without offering additional weight loss benefits
The antioxidant capacity of silymarin can lower oxidative stress (in the liver) associated with acetaminophen metabolism in rats, which has the effect of conserving cellular glutathione levels (Campos 1989)
Note that the therapeutic indication for all of these drugs is for type 2 diabetes, with the exception of Wegovy (2.4 mg/week of semaglutide by subcutaneous injection), which was recently approved for weight loss
J Gastroenterol Hepatol 23:e428e431
